Chen Shao Selected Research

Breast Neoplasms (Breast Cancer)

1/2021	Identification of predictors based on drug targets highlights accurate treatment of goserelin in breast and prostate cancer.
1/2021	STIM1 promotes angiogenesis by reducing exosomal miR-145 in breast cancer MDA-MB-231 cells.
2/2015	IR-780 dye for near-infrared fluorescence imaging in prostate cancer.
1/2012	Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chen Shao Research Topics

Disease

39	Neoplasms (Cancer) 05/2022 - 12/2005
22	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2005
9	Atherosclerosis 12/2022 - 03/2017
8	Fibrosis (Cirrhosis) 12/2022 - 03/2015
6	Hypoxia (Hypoxemia) 11/2020 - 07/2011
5	Vascular Calcification 12/2022 - 03/2017
5	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2011
5	Inflammation (Inflammations) 01/2022 - 01/2018
5	Glioma (Gliomas) 06/2018 - 03/2014
4	Renal Cell Carcinoma (Grawitz Tumor) 05/2022 - 03/2003
4	Chronic Hepatitis B 01/2022 - 05/2017
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2012
4	Kidney Neoplasms (Kidney Cancer) 01/2021 - 03/2003
4	Circulating Neoplastic Cells 09/2016 - 06/2013
3	Acute Liver Failure (Fulminant Hepatic Failure) 12/2022 - 01/2018
3	Necrosis 10/2022 - 02/2014
3	Carcinogenesis 05/2022 - 07/2014
3	Infections 12/2021 - 11/2013
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 03/2017
3	Leukemia 06/2019 - 06/2014
3	Lung Neoplasms (Lung Cancer) 02/2015 - 08/2012
2	Liver Diseases (Liver Disease) 12/2022 - 09/2021
2	Liver Failure 12/2022 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2017
2	Chronic Disease (Chronic Diseases) 01/2022 - 04/2021
2	Coronary Disease (Coronary Heart Disease) 01/2021 - 04/2019
2	COVID-19 11/2020 - 01/2020
2	Diabetic Foot 01/2020 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2020 - 06/2015
2	Diabetes Mellitus 01/2020 - 10/2018
2	Hypersensitivity (Allergy) 06/2019 - 12/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 04/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 05/2017
2	Colonic Neoplasms (Colon Cancer) 04/2016 - 04/2016
2	Carcinoma (Carcinomatosis) 04/2016 - 02/2015
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2014 - 07/2008
2	Osteoporosis 07/2013 - 03/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012 - 04/2012
2	Wounds and Injuries (Trauma) 12/2011 - 07/2008
2	Azoospermia 12/2009 - 07/2009

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2005
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
7	Apolipoproteins E (ApoE)IBA 12/2022 - 03/2017
7	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
5	MicroRNAs (MicroRNA)IBA 12/2021 - 09/2014
5	Coloring Agents (Dyes)IBA 02/2015 - 02/2013
4	Protein Kinases (Protein Kinase)IBA 05/2022 - 05/2015
4	ProteomeIBA 01/2022 - 07/2008
4	Peptides (Polypeptides)IBA 10/2021 - 01/2012
4	EnzymesIBA 01/2020 - 07/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 07/2008
4	Androgen Receptors (Androgen Receptor)IBA 10/2019 - 12/2005
4	CarbocyaninesIBA 02/2015 - 02/2013
4	Messenger RNA (mRNA)IBA 08/2012 - 12/2003
3	ApolipoproteinsIBA 01/2022 - 03/2017
3	Antiviral Agents (Antivirals)IBA 12/2021 - 05/2017
3	Biological ProductsIBA 10/2021 - 03/2003
3	matrigelIBA 01/2021 - 03/2017
3	Galectin 3 (LGALS3)IBA 01/2021 - 04/2019
3	Phosphotransferases (Kinase)IBA 01/2019 - 01/2013
3	Contrast MediaIBA 04/2018 - 11/2014
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2022 - 04/2016
2	Alanine Transaminase (SGPT)IBA 01/2022 - 11/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2014
2	Photosensitizing Agents (Photosensitizers)IBA 11/2020 - 01/2018
2	phytochlorinIBA 11/2020 - 12/2015
2	Advanced Glycation End ProductsIBA 01/2020 - 10/2018
2	VaccinesIBA 01/2020 - 07/2011
2	PolymersIBA 12/2019 - 06/2013
2	BilirubinIBA 08/2019 - 04/2018
2	Immunoglobulin E (IgE)IBA 06/2019 - 12/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2019 - 09/2014
2	entecavir FDA Link 01/2019 - 05/2017
2	ManganeseIBA 06/2018 - 06/2015
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 04/2016
2	VimentinIBA 09/2016 - 03/2015
2	Staphylococcal Protein A (Protein A)IBA 02/2015 - 01/2012
2	Polo-Like Kinase 1IBA 01/2015 - 11/2014
2	AndrogensIBA 11/2014 - 11/2007
2	MHI-148IBA 09/2014 - 02/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2014 - 07/2014
2	IR-783IBA 01/2014 - 02/2013
2	Blood Proteins (Serum Proteins)IBA 01/2013 - 07/2008
2	Small Interfering RNA (siRNA)IBA 12/2011 - 07/2011
2	Complementary DNA (cDNA)IBA 07/2009 - 03/2003
1	AlbuminsIBA 12/2022
1	Serum AlbuminIBA 12/2022
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2022
1	Sorafenib (BAY 43-9006)FDA Link 05/2022
1	Serine (L-Serine)FDA Link 05/2022
1	Glucagon (Glukagon)FDA Link 04/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2022

Therapy/Procedure

15	Therapeutics 01/2022 - 12/2013
4	Drug Therapy (Chemotherapy) 12/2019 - 08/2012
3	Castration 01/2022 - 11/2014
3	Photochemotherapy (Photodynamic Therapy) 11/2020 - 12/2015
3	Lasers (Laser) 11/2020 - 06/2013
2	Surgical Amputation (Amputations) 01/2020 - 01/2020